Fallopian Tube Carcinoma — Trials

Fallopian Tube Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

213 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 77
Recruiting: 29
Ph III recruiting: 4
Growth YoY: —
Industry share: 9%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (31)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07764744	Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic Variants(OC-LEAD)	not yet recruiting	N/A	70	Weill Medical College of Cornell UniversityOTHER	1	Sep 11, 2026	clinicaltrials
NCT06846424	SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer	not yet recruiting	Phase 1	24	Shanghai Gynecologic Oncology GroupOTHER_GOV	1	Feb 26, 2025